D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin.
about
(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signalingPathways and networks-based analysis of candidate genes associated with nicotine addictionSchizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerizationD2 dopamine receptor expression and trafficking is regulated through direct interactions with ZIPA Systematic Analysis of Candidate Genes Associated with Nicotine Addiction.Dopamine 5 receptor mediates Ang II type 1 receptor degradation via a ubiquitin-proteasome pathway in mice and human cells.Brain region-specific N-glycosylation and lipid rafts association of the rat mu opioid receptorNovel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability.Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.Mapping of domains on HIV envelope protein mediating association with calnexin and protein-disulfide isomeraseChaperoning G protein-coupled receptors: from cell biology to therapeuticsDopamine receptor expression and distribution dynamically change in the rat nucleus accumbens after withdrawal from cocaine self-administration.Identification of RanBP 9/10 as interacting partners for protein kinase C (PKC) gamma/delta and the D1 dopamine receptor: regulation of PKC-mediated receptor phosphorylation.C-terminal di-leucine motif of dopamine D₁ receptor plays an important role in its plasma membrane trafficking.Regulation of M₃ muscarinic receptor expression and function by transmembrane protein 147.The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail.Imaging the Insertion of Superecliptic pHluorin-Labeled Dopamine D2 Receptor Using Total Internal Reflection Fluorescence Microscopy.An anticholinergic reverses motor control and corticostriatal LTD deficits in Dyt1 ΔGAG knock-in mice.Peptide-based interactions with calnexin target misassembled membrane proteins into endoplasmic reticulum-derived multilamellar bodies.Acetylcholine α7 nicotinic and dopamine D2 receptors are targeted to many of the same postsynaptic dendrites and astrocytes in the rodent prefrontal cortex.Fixation strategies for retinal immunohistochemistry.Identifying novel protein-protein interactions using co-immunoprecipitation and mass spectroscopy.Reciprocal modulation of function between the D1 and D2 dopamine receptors and the Na+,K+-ATPaseN-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic.Complement factor 5a receptor chimeras reveal the importance of lipid-facing residues in transport competence.CD4-CCR5 interaction in intracellular compartments contributes to receptor expression at the cell surfaceMolecular pathways in dystonia.Dopamine and renal function and blood pressure regulation.A synergistic approach towards understanding the functional significance of dopamine receptor interactions.A missense mutation in Grm6 reduces but does not eliminate mGluR6 expression or rod depolarizing bipolar cell function.N-Glycan-dependent and -independent quality control of human δ opioid receptor N-terminal variants.The Cacna1h mutation in the GAERS model of absence epilepsy enhances T-type Ca2+ currents by altering calnexin-dependent trafficking of Cav3.2 channels.Gene expression profiling of the dorsolateral and medial orbitofrontal cortex in schizophrenia.N-glycan-mediated quality control in the endoplasmic reticulum is required for the expression of correctly folded delta-opioid receptors at the cell surface.Intranasal delivery of a peptide with antidepressant-like effect.Regional expression of dopamine D1 and D2 receptor proteins in the cerebral cortex of asphyxic newborn infants.Functional analysis of the Notch ligand Jagged1 missense mutant proteins underlying Alagille syndrome.
P2860
Q28248215-31B06FC1-4658-478D-9396-2654B8D31D1CQ28547199-D6904307-90A2-45BF-8D4D-F09571507331Q28567232-F1F92BE1-1DC3-406B-8A45-B4D3BF674991Q28581786-3AF3DB4D-41E8-4C7E-8FFA-0A390EF2717AQ30384681-37F1C465-C2FA-4EC4-9711-E5FAC343FE52Q30441613-05593EF7-F2A4-4C3F-8BA2-09197771D50EQ33589637-9476A120-2E85-4E62-8764-CF61231CE105Q33669652-7E82F64A-73DF-42B1-9C40-8AEB92CE7AC7Q33751420-4C1FE0A0-6E53-46C3-B4B3-4F7D556D0B67Q33810106-83A61B9D-B965-41B5-B55D-2019177597AEQ33927508-32523B3B-1247-444F-8524-9BD5D49DE88CQ33983589-6C5D55C3-C65F-47A0-A209-8E59105603DCQ34028214-5CBDD0A7-9C6C-40D4-B69B-2BB5064C937EQ34113700-55717267-9C09-43FF-8B1D-6CED34E3CBFAQ34552040-D89BB80A-9A64-4CC9-81E5-62B3FC9ED3D5Q34663357-CDACFC1E-23C4-431E-A3F8-5B7685DFC498Q35013244-AD301478-4E1C-4EBF-9721-F1A2F716F84DQ35576523-10D0A1EE-A95A-41BB-9693-9FE4AAF9B50DQ35825535-6CEB5F0A-9E1A-42CB-A710-2A0822C95F6AQ35975080-653AD2A8-65F8-44DC-8F7C-98797010A215Q35977967-5523BC2C-2D55-402D-98F0-33E1E7E0037BQ36575874-BE45FE26-DB37-4C0D-A68A-21317E712ABFQ37021538-39446DE3-C758-4B42-8A10-EE5B46BDC9CEQ37234365-C68ED808-BC85-4305-90D6-69B1DF7FB409Q37354853-3BC4EADA-2C71-48B3-8AFC-6C42364B16C8Q37475747-A6397A18-ACBF-46AF-B700-D567B58CB658Q37816579-28612E42-55EF-405A-9584-7B87F9094349Q38111703-4D04443F-C562-4D12-91D2-554BFBA72E39Q38168871-BC107941-2EF6-40A9-AA55-A45F7502B004Q38793661-FA54F87D-80E2-4330-892A-BEB805BB25E3Q41020895-976FD813-464C-419A-8E3D-7806B6ED765AQ41044294-332FAD12-88BF-4287-A038-4550A1C5FBFEQ41874352-9AC0E679-14DF-404E-B774-45AE8AE764C4Q41929065-D9C8338E-438C-4B35-98AF-B8835AA9911CQ41979813-1F774F25-C774-48D9-90EB-BE27FF6962ECQ46139286-5969BDFA-222E-45F6-81A1-DA7306B64751Q53175186-21386B97-02CE-43B5-94DA-2FCDA75D77ED
P2860
D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
D1 and D2 dopamine receptor ex ...... he chaperone protein calnexin.
@en
type
label
D1 and D2 dopamine receptor ex ...... he chaperone protein calnexin.
@en
prefLabel
D1 and D2 dopamine receptor ex ...... he chaperone protein calnexin.
@en
P2093
P2860
P356
P1476
D1 and D2 dopamine receptor ex ...... he chaperone protein calnexin.
@en
P2093
David M Cabrera
David R Sibley
Heather N Spalding
Lisa A Hazelwood
Michele L Rankin
R Benjamin Free
Yoon Namkung
P2860
P304
21285-21300
P356
10.1074/JBC.M701555200
P407
P577
2007-03-29T00:00:00Z